Summary of Consolidated Financial Results | IR Filing

Download the Materials

Our Business

Discover TOHO HOLDINGS

Our Business TOP

Pharmaceutical Wholesaling Business

Dispensing Pharmacy Business

Pharmaceutical Manufacturing and Sales Business

Others

Corporate Information

Corporate Information TOP

Investor Relations

TOHO HOLDINGS at a Glance

Investor Relations TOP

Sustainability

Sustainability TOP

Investor Relations
IR Filing
Summary of Consolidated Financial Results

Investor RelationsSummary of Consolidated Financial Results

Financial Results of the fiscal year ended March 2021 or before, please click here.

FY ending March 2027

First Quarter （349KB）

FY ended March 2026

Full Year （596KB）
Third Quarter （303KB）
First Half （458KB）
First Quarter （347KB）

FY ended March 2025

Full Year （601KB）
Third Quarter （390KB）
First Half （412KB）
First Quarter （471KB）

FY ended March 2024

Full Year （591KB）
Third Quarter （390KB）
First Half （507KB）
First Quarter （364KB）

FY ended March 2023

Full Year （536KB）
Third Quarter （365KB）
First Half （504KB）
First Quarter （389KB）

FY ended March 2022

Full Year （570KB）
Third Quarter （474KB）
First Half （399KB）
First Quarter （379KB）

IR Information

Investor RelationsTOHO HOLDINGS at a Glance

Investor RelationsManagement Policy

Investor RelationsMedium-term management plan

Investor RelationsFinancial Data

Investor RelationsIR Filing

Investor RelationsStock Information

Investor RelationsIR Calendar

Investor RelationsRisk Information

Investor RelationsElectronic Public Notice

Investor RelationsDisclaimer

Investor RelationsDownload the Materials

If you agree to the use of cookies, please click the "Agree" button.
If you do not agree, please do not use this site. For details, please refer to the following page.